1. Home
  2. IPAR vs TLX Comparison

IPAR vs TLX Comparison

Compare IPAR & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inter Parfums Inc.

IPAR

Inter Parfums Inc.

N/A

Current Price

$112.00

Market Cap

3.7B

ML Signal

N/A

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$11.24

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IPAR
TLX
Founded
1982
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.9B
IPO Year
1995
2024

Fundamental Metrics

Financial Performance
Metric
IPAR
TLX
Price
$112.00
$11.24
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
★ $126.50
$20.37
AVG Volume (30 Days)
168.0K
★ 476.7K
Earning Date
11-04-2026
10-15-2026
Dividend Yield
★ 2.87%
N/A
EPS Growth
★ 2.34
N/A
EPS
★ 2.31
N/A
Revenue
★ $1,317,700,000.00
N/A
Revenue This Year
$0.03
$15.87
Revenue Next Year
$7.18
$13.93
P/E Ratio
★ $48.31
$150.33
Revenue Growth
★ 21.26
N/A
52 Week Low
$77.21
$6.28
52 Week High
$129.29
$13.11

Technical Indicators

Market Signals
Indicator
IPAR
TLX
Relative Strength Index (RSI) 44.74 48.99
Support Level $109.13 $11.20
Resistance Level $119.40 $11.48
Average True Range (ATR) 3.10 0.23
MACD -0.23 -0.04
Stochastic Oscillator 16.08 47.27

Price Performance

Historical Comparison
IPAR
TLX

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: